INKT · MiNK Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Mink Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Pioneering The Discovery, Development And Manufacturing Of Allogeneic, Off-The-Shelf, Invariant Natural Killer T (Inkt) Cell Therapies To Treat Cancer And Other Immune-Mediated Diseases. Inkt Cells Offer Distinct Therapeutic Advantages As A Platform For Allogeneic Therapy In That The Cells Naturally Home To Tissues, Aid Clearance Of Tumors And Infected Cells, And Suppress Graft-Versus-Host-Disease. Its Product Candidate, Agent-797, Is An Off-The-Shelf, Allogeneic, Native Inkt Cell Therapy. It Operates Its Business In Single Segment.

HealthcareNasdaqUSVery Low Float

FLOAT

2.0M

FREE FLOAT %

39%

SHARES O/S

5.1M

MARKET CAP

$54.7M

EXCHANGE

Nasdaq

COUNTRY

INKT Catalyst History

No catalysts recorded for INKT yet

Day Trader Sniper hasn't classified a publishable catalyst for INKT yet. New events appear here as they're scored.

Be early on the next INKT spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

INKT · MiNK Therapeutics, Inc.

INKT Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.